ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Entire Construction Budget In 1983 Goes to Two Grants; Help May Be On The Way

February 25, 1983

Sloan-Kettering Cited For 8 Violations Of NY State Standards

November 24, 1995

NCI Sends Letter To Grantees To Explain Tighter Funding.

March 16, 2001

In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire

June 11, 1993

Georgetown Sponsors Oncology Agent Development Meeting

February 21, 2003

Hospital to Review Medenica’s Privileges, With Conditions

November 5, 1993